WATSON 395 50 0 .5 (Naloxone Hydrochloride and Pentazocine Hydrochloride 0.5 mg / 50 mg)

Pill with imprint WATSON 395 50 0 .5 is Green, Elliptical / Oval and has been identified as Naloxone Hydrochloride and Pentazocine Hydrochloride 0.5 mg / 50 mg. It is supplied by Watson Pharmaceuticals.

Naloxone/pentazocine is used in the treatment of chronic pain; pain and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Naloxone/pentazocine 0.5 mg / 50 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for WATSON 395 50 0 .5

Naloxone hydrochloride and pentazocine hydrochloride 0.5 mg / 50 mg WATSON 395 50 0 .5

Naloxone hydrochloride and pentazocine hydrochloride 0.5 mg / 50 mg WATSON 395 50 0 .5 Front

Naloxone Hydrochloride and Pentazocine Hydrochloride

Imprint: WATSON 395 50 0 .5
Strength: 0.5 mg / 50 mg
Color: Green
Size: 13.00 mm
Shape: Elliptical / Oval
Availability: Prescription only
Drug Class: Narcotic analgesic combinations
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: 4 - Some potential for abuse
Labeler / Supplier: Watson Pharmaceuticals
Inactive Ingredients: silicon dioxide, calcium phosphate dibasic anhydrous, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Yellow No. 6, magnesium stearate, microcrystalline cellulose, corn starch, sodium lauryl sulfate
Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code	Labeler / Repackager
00591-0395	Watson Pharmaceuticals, Inc.
66267-0487 (Discontinued)	Nucare Pharmaceuticals Inc. (repackager)
63874-0220 (Discontinued)	Altura Pharmaceuticals Inc. (repackager)
43063-0142 (Discontinued)	PDRX Pharmaceuticals Inc. (repackager)
35356-0176 (Discontinued)	Lake Erie Medical and Surgical Supply (repackager)